<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25252895</PMID><DateCompleted><Year>2015</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0065-2598</ISSN><JournalIssue CitedMedium="Print"><Volume>836</Volume><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Advances in experimental medicine and biology</Title><ISOAbbreviation>Adv Exp Med Biol</ISOAbbreviation></Journal><ArticleTitle>Detection of Influenza and Other Respiratory Viruses Carried Out in the Influenza Project - Monitoring Vaccine Effectiveness (I-MOVE).</ArticleTitle><Pagination><StartPage>29</StartPage><EndPage>33</EndPage><MedlinePgn>29-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/5584_2014_31</ELocationID><Abstract><AbstractText>The project Influenza Vaccine Effectiveness-Monitoring (I-MOVE) is part of the European research carried out by the ECDC (European Center for Disease Prevention and Control), aimed at monitoring the effectiveness of vaccination in Europe during the growing incidence of flu and influenza-like illnesses in the coming epidemic seasons. Laboratory studies using molecular RT-PCR biology methods for detection of genetic material of influenza virus and other respiratory viruses were performed by Voivodeship Sanitary-Epidemiological Stations in Poland. The validation of the results of swabs taken from the nose and throat were carried out in the Department of Influenza Research, National Influenza Center in Warsaw. The study involved 210 samples from patients across Poland. Positive results were recorded for 72.4 % of the samples; influenza virus type A was detected in 43 and type B in 38 cases, whereas in 71 cases other respiratory viruses were detected, which included Human parainfluenza virus type 1-4; Human respiratory syncytial virus type A and B; Human coronavirus 229E/NL63, OC43; Human rhinovirus type A, B, and C; Human enterovirus; and Human adenovirus. The results show that although influenza viruses predominated in the 2010/2011 season in Poland, other flu-like viruses also abounded.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wo&#x17a;niak-Kosek</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Influenza Research, National Influenza Center, National Institute of Public Health-National Institute of Hygiene, 24 Chocimska St., 00-791, Warsaw, Poland, kaj12@poczta.fm.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Adv Exp Med Biol</MedlineTA><NlmUniqueID>0121103</NlmUniqueID><ISSNLinking>0065-2598</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D062665" MajorTopicYN="N">Epidemiological Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005062" MajorTopicYN="N">European Union</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009975" MajorTopicYN="N">Orthomyxoviridae</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011044" MajorTopicYN="N" Type="Geographic">Poland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018108" MajorTopicYN="N">Respirovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>4</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25252895</ArticleId><ArticleId IdType="pmc">PMC7121447</ArticleId><ArticleId IdType="doi">10.1007/5584_2014_31</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brydak LB. Diagnostics, prophylaxis and treatment of influenza in the practice of a family physician. Med Stand/Pediatr. 2008;5:261&#x2013;269.</Citation></Reference><Reference><Citation>Brydak LB, Wozniak-Kosek A, Nitsch-Osuch A. Influenza diagnosis and vaccination in Poland. Respir Physiol Neurobiol. 2013;187:88&#x2013;93. doi: 10.1016/j.resp.2013.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2013.02.008</ArticleId><ArticleId IdType="pmc">PMC7105210</ArticleId><ArticleId IdType="pubmed">23419518</ArticleId></ArticleIdList></Reference><Reference><Citation>ECDC &#x2013; European Centre for Disease Prevention and Control (2013) http://ecdc.europa.eu/en/activities/surveillance/eisn/surveillance/pages/influenza_case_definitions.aspx. Accessed on 03 Feb 2014</Citation></Reference><Reference><Citation>Globinska A, Kowalski ML. Natural immunological response to respiratory viruses &#x2013; intracellular signalling pathways. Allergy Ashtma Immunol. 2012;17(2):66&#x2013;75.</Citation></Reference><Reference><Citation>Kissling E, Valenciano M, Cohen MJ, Oroszi B, Barret AS, Rizzo C, Stefanoff P, Nunes B, Pitigoi D, Larrauri A, Daviaud I, Horvath JK, O&#x2019;Donnell J, Seyler T, Paradowska-Stankiewicz IA, Pechirra P, Ivanciuc AE, Jim&#xe9;nez-Jorge S, Savulescu C, Ciancio BC, Moren A. I-MOVE multicentre case control study 2010&#x2013;11: overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS One. 2011;6(11):e27622. doi: 10.1371/journal.pone.0027622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0027622</ArticleId><ArticleId IdType="pmc">PMC3216983</ArticleId><ArticleId IdType="pubmed">22110695</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitsch-Osuch A, Wozniak-Kosek A, Korzeniewski K, Zycinska K, Wardyn K, Brydak LB. Accuracy of the rapid influenza detection test in the diagnosis of influenza A and B viruses in children less than 59 months old. Adv Exp Med Biol. 2013;788:71&#x2013;76. doi: 10.1007/978-94-007-6627-3_11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-94-007-6627-3_11</ArticleId><ArticleId IdType="pubmed">23835961</ArticleId></ArticleIdList></Reference><Reference><Citation>Romanowska M, Brydak LB. Family physicians as the basis for the functioning of the integrated epidemiological and virological SENTINEL surveillance of influenza. New Clin. 2007;14:1166&#x2013;1175.</Citation></Reference><Reference><Citation>Van-Tam J, Sellwood C, editors. Pandemic influenza. 2. Wallingford: CAB International; 2013.</Citation></Reference><Reference><Citation>Wozniak-Kosek A, Brydak LB. Virological monitoring of influenza activity and influenza-like illnesses in the epidemic season of 2011/2012 in Poland. Adv Exp Med Biol. 2013;788:77&#x2013;82. doi: 10.1007/978-94-007-6627-3_12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-94-007-6627-3_12</ArticleId><ArticleId IdType="pubmed">23835962</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>